Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill

DOI: 10.1186/s12959-019-0196-6

Keywords: Venous thromboembolism, Cancer, Critically ill, Anticoagulants, Low-molecular-weight heparin

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s12959-019-0196-6) contains supplementary material, which is available to authorized users

Full-Text